Prolactinomas

3 registered clinical trials studyying Prolactinomas.

Status	Trial	Sponsor	Phase
Completed	Response to Cabergoline and Pasireotide in Non-functioning Pituitary Adenomas and Resistant Prolactinomas NCT01620138	Universidade Federal do Rio de Janeiro	Phase 2 / Phase 3
Completed	Targeted Therapy With Lapatinib in Patients With Recurrent Pituitary Tumors Resistant to Standard Therapy NCT00939523	Cedars-Sinai Medical Center	Phase 2
Completed	Cardiac Valve Complications in Prolactinomas Treated With Cabergoline NCT00460616	Federico II University	—